Gsa Capital Partners LLP Gsk PLC Transaction History

Gsa Capital Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$40.23 - $47.74 $346,943 - $411,709	-8,624 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $335,301 - $390,753	8,624 New	8,624 $380,000
Q2 2021 Aug 05, 2021	SELL	$36.52 - $41.46 $321,120 - $364,557	-8,793 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$34.27 - $40.01 $301,336 - $351,807	8,793 New	8,793 $314,000
Q1 2020 May 12, 2020	SELL	$32.47 - $48.83 $240,278 - $361,342	-7,400 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$42.0 - $48.25 $310,800 - $357,050	7,400 New	7,400 $348,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.9B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.